top of page
GWAS reveals mechanisms underlying DCM and myocardial resilience
01:01:05
Risk modeling in cardiomyopathies
01:05:44
The complex spectrum of Mendelian genetics in cardiomyopathies
59:05
Emerging Therapies for TransthyretinCardiac Amyloidosis
56:34
Functional studies on Z-disc proteins and their role in cardiomyopathies
58:22
Exercise recommendations in cardiomyopathies
56:28
Cardiac outcomes in mitochondrial disease
56:12
The importance of the genotype on top of phenotype in managing dilated cardiomyopathies.
56:26
Tracking and treating heart muscle inflammation.
01:02:23
Association between prophylactic ACEinhibitors and overall survival in Duchennemuscular dystrophy
58:43
Population prevalence of premature truncating variants in PKP2 and association with ARVC.
58:57
We see, but do not observe. Arrhythmogenic Cardiomyopathy revisited.
59:16
State-of-the-art human models to test effectiveness of old and new drugs for cardiomyopathies
01:03:41
Natural History of HCM in NoonanSyndrome with MultipleLentigines (LEOPARD Syndrome)
09:52
Genetics in Arrhythmogenic Cardiomyopathy and implications for clinical practice
32:44
Genetic Variants and outcomes in non-ischaemic dilated cardiomyopathy
16:11
Connect

Subscribe to keep up-to-date with future Heart Muscle Talks!

Thanks, we got it! If you have not received a confirmation email, please check your spam folder and add heartmuscletalks@gmail.com to your contacts.

©2023 by NWS. Proudly created with wix.com

bottom of page